Document:

EXHIBIT
      10.18

     

    Addendum
      to the Technology License Agreement

     

    between

     

    The
      Research Foundation of State University of New York

    for
      and on behalf of University at Buffalo

     

    and

     

    Donald
      D. Hickey, M.D.

     

    and

     

    Clas
      E. Lundgren, M.D., Ph.D.

     

    and

     

    Scivanta
      Medical Corporation

    

    This
      Addendum to the Technology License Agreement (this “Agreement”) is entered into
      this 29th day of June, 2007 (the “Effective Date”) by and between The Research
      Foundation of State University of New York, for and on behalf of University
      at
      Buffalo, a non-profit corporation organized and existing under the laws of
      the
      State of New York (the “Foundation”), Donald D. Hickey, M.D. (“Hickey”) and Clas
      E. Lundgren, M.D., Ph.D. (a/k/a Claes Lundgren and referenced herein as
“Lundgren”) and Scivanta Medical Corporation (formerly Medi-Hut Co., Inc.), a
      corporation duly organized under the laws of the State of Nevada, and having
      its
      principal place of business at 215 Morris Avenue, Spring Lake, New Jersey 07762
      (“Licensee”). Foundation, Hickey and Lundgren will be collectively referenced
      herein as “Licensor”.

     

    WHEREAS,
      Licensor and Licensee entered into an exclusive Technology License Agreement
      on
      November 10, 2006, to facilitate the development and commercialization of
      certain technology owned by Licensor so that this technology may be utilized
      to
      the fullest extent for the benefit of Licensee, Licensor, the inventor(s) and
      the public;

     

    WHEREAS,
      Licensor has or will enter into a “Research Agreement” and a “Manufacturing
      License Agreement” with Ethox International, Inc. (“Ethox”) to further
      facilitate the development and commercialization of the licensed technology
      (“Scivanta Ethox Agreements”);

     

    WHEREAS,
      Licensee has or will enter into a “Project Development Agreement” and a “Supply
      Agreement” with Ethox (the “Scivanta Ethox Agreements”) to set forth the terms
      and conditions under which Ethox shall engineer, develop and manufacture key
      components of the Hickey Cardiac Monitoring System (“HCMS”); 

     

    WHEREAS,
      Licensor and Licensee desire to modify the aforementioned Technology License
      Agreement for the mutual benefit of both parties;

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    NOW,
      THEREFORE, in consideration of the mutual promises and covenants contained
      herein and good and valuable consideration, the receipt of which is hereby
      acknowledged, the parties agree as follows:

     

    
      	1. 
                	
              The
                modifications of the Technology License Agreement herein will be
                effective
                as of the Effective Date and will remain in effect for the duration
                of the
                Technology License Agreement unless further modified in writing by
                the
                parties hereto.

            

    

    

    
      	2. 
                	
              Section
                2.1 of the Technology License Agreement will be replaced
                with:

            

    

    

    2.1 Exclusive
      License. Licensor
      grants to Licensee an exclusive license under its Technology rights to (a)
      develop, make, have made, use, sell and offer for sale or otherwise exploit
      the
      Licensed Products, and (b) use and reproduce Software, create Derivatives,
      and
      distribute Software to end-users through the normal channels of distribution,
      in
      the Field and Territory during the Term. Licensee will have the unrestricted
      right to develop Licensee Improvements relating to the Licensed Products in
      the
      United States for distribution and exploitation of the Licensed Products either
      in the United States or outside of the United States. Licensee will also have
      the unrestricted right to develop Licensee Improvements relating to the Licensed
      Products in any foreign country for distribution and exploitation of the
      Licensed Products in any other country, including the U.S. Notwithstanding
      the
      exclusive license granted to Licensee, Licensee hereby consents to Licensor’s
      grant of a limited, non-exclusive license to Ethox for the sole purpose of
      the
      engineering, development and manufacture of the catheter component of the Hickey
      Cardiac Monitoring System (“HCMS”) in accordance with the Scivanta Ethox
      Agreements. Licensor and Licensee agree that such limited licensed rights will
      be granted only to Ethox under a separate manufacturing license agreement
      (“Ethox Agreement”) and no other party. If for any reason the Ethox Agreement or
      the Scivanta Ethox Agreements are terminated or expire, the limited license
      granted to Ethox hereunder will immediately terminate and all exclusive license
      rights will remain with Licensee.

     

    
      	3.  
               	
              Section
                6.1 of the Technology License Agreement will be amended to change
                the
                November 1, 2008, Payment Amount to Hickey and Lundgren from $109,578
                to
                $108,235.

            

    

    

    
      	4. 
                	
              Other
                than as specifically modified in this Addendum, all other terms,
                conditions and covenants of the Technology License Agreement entered
                into
                on November 10, 2006 shall remain in full force and
                effect.

            

    

    

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the undersigned duly authorized representatives of the parties
      have executed this Agreement, effective on the date first written
      above.

     

    

    
      	
              SCIVANTA
                MEDICAL CORPORATION

            	
              THE
                RESEARCH FOUNDATION OF 

            
	
            	
              STATE
                UNIVERSITY OF 

            
	
            	
              NEW
                YORK

            
	 	 
	
              By:
                /s/ David R.
                LaVance                                   
                

            	
              By:
                /s/ Woodrow
                Maggard                                  
                

            
	
                    
                David R. LaVance

            	
                    
                Woodrow Maggard

            
	 	 
	
              Title:
                President and Chief Executive Officer

            	
              Title:
                Assistant Vice Provost, STOR

            
	 	 
	
              Date:
                June 29, 2007

            	
              Date:
                June 29, 2007

            
	 	 
	 	 
	
              DONALD
                D. HICKEY, M.D.

            	
              CLAS
                E. LUNDGREN, M.D., Ph.D.

            
	 	 
	
              By:
                /s/ Donald D. Hickey,
                M.D.                        
                

            	
              By:
                /s/ Clas E. Lundgren, M.D.,
                Ph.D.                

            
	
                    
                Donald D. Hickey, M.D.

            	
                    
                Clas E. Lundgren, M.D., Ph.D.

            
	 	 
	
              Date:
                June 29, 2007

            	
              Date:
                June 29, 2007

            

    

    

    

     

    
      
        
        

      

      
        3EXHIBIT
      10.19

    

    

    
      
        

      

    

    Hickey
      Cardiac Monitoring System

     

    A
      Proposal for Services to

     

    Scivanta
      Medical Corporation

     

      
        

      

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    
      	
              Presented
                To:    

            	
              Scivanta
                Medical Corporation

              David
                LaVance 

              Tom
                Gifford

              215
                Morris Ave

              Spring
                Lake, NJ 07762

            
	 	 

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Hickey
      Cardiac Monitoring System

     

    Section
      I: Scope of Work

     

    Applied
      Sciences Group, Inc.
      (“ASG”)
      will provide the software engineering services as defined in this proposal.
      

     

    As
      a
      provider of engineering solutions in the areas of factory automation, high
      tech
      and project management since 1993, ASG is a qualified provider for the Hickey
      Cardiac Monitoring System project in accordance with the mission of the company:
      

     

    ASG
      will
      provide technically superior engineering solutions for applications involving
      research, industrial and manufacturing environments, design-oriented engineering
      services, technical project management and training. Our service will be easily
      integrated by our customers, as we will blend into their structure while
      illustrating outstanding business ethics and superior technical
      expertise.

     

    Problem
      Statement

     

    Scivanta
      Medical Corporation (“Scivanta”), Ethox International, Inc. (“Ethox”) and ASG
      have been charged with developing an FDA-validated instrument to measure key
      cardiac parameters, based on an esophageal catheter and associated
      instrumentation. ASG’s role is to provide the control, data capture, data
      processing and display software for the instrument.

     

    Approach

     

    Over
      the
      past several months, task details have been developed and presented to Scivanta
      and Ethox based on the agreed-to roles and responsibilities of each involved
      party. In summary:

     

    	· 
              	
            Ethox
              will provide overall engineering program management, quality assurance,
              design and development of the catheter
              component;

          

    	· 
              	
            A
              hardware developer, to be determined, will provide instrument electronics
              development and board-level software to provide a pump and electronics
              interface to the high-level software;

          

    	· 
              	
            ASG
              will develop the software algorithms to run the instrument, the data
              collection function and the user
              interface.

          

     

    All
      parties will participate in engineering meetings, testing and validation
      efforts. Some travel will be required and is included in this
      proposal.

     

    The
      following tables outline the major software engineering development tasks that
      must be completed prior to FDA product approvals. Many of these tasks are
      dependent on the hardware developer’s schedule and availability of development
      equipment (see assumptions below).

     

    Phase
      I Tasks: Catheter Position Algorithm, Requirements Definition and High-Level
      Design

     

    Phase
      I
      Tasks, as defined in this proposal, are those tasks whose levels of effort
      can
      be accurately estimated. Four tasks have been identified that fit into this
      category. These tasks include the engineering review of the original prototype’s
      software functionality, engineering analysis and 

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    re-design
      of the original prototype’s catheter positioning algorithm (and requisite data
      collection effort), the new product’s requirements analysis and specification,
      and the high-level design efforts. These tasks are specified in the table
      below.

     

    
      	
              Phase
                I: ASG Engineering Estimates (Fixed Price Tasks)

            	
              Effort
                (Hours)

            
	 	 
	
               Review
                and Document Existing Software

              ·  Pump
                Control

              ·  Display
                Functionality

              ·  Dispatch
                Functionality

              ·  Watchdog
                Functionality

              ·  Data
                Analysis

              ·  Configuration

              ·  Communications
                Interfaces

            	
              224

            
	
               Re-Analyze
                and Develop Catheter Positioning Algorithm

              ·  Perform
                Engineering Analysis of previous prototype software, review signal
                processing

                     
                algorithms, collect data for analysis, analyze results and provide
                design
                recommendations, 

                     
                and document results.

              ·  Review
                software interaction with Pump Control process, Dispatch and
                Communications

                      
                Processes, provide design recommendations, and document
                results.

            	
              308

            
	
               Develop
                System Specification(s)

              ·  Meetings
                to discuss quality and project plans

              ·  Determine
                system and software requirements

              ·  Perform
                risk/hazard analysis on all software requirements

              ·  Perform
                traceability study

              ·  Generate
                system-level test plan

              ·  Generate
                standards documentation

            	
              236

            
	
               Perform
                High-Level Design

              ·  Specify
                HW platform, SW tools and configuration management system

              ·  Determine
                processor allocations (CPU, memory, storage)

              ·  Develop
                hardware and software interface design specification

              ·  Update
                risk/requirements documents based on findings

              ·  Create
                high-level software definition

              ·  Perform
                design reviews

            	
              244

            
	
               Total
                Phase I (Fixed Price) Tasks (hours)

            	
              1008

            
	
               Phase
                I Duration (Weeks)

            	
              13

            
	
               Phase
                I Engineering Cost

            	
              $80,640

            
	
               Phase
                I PM/QA Cost

            	
              $22,100

            
	
               Phase
                I Travel Cost (Estimated)

            	
              $2,500
                

            
	
               Phase
                I Total

            	
              $105,240

            

    

     

    Note:
      The
      Phase I catheter position analysis requires timely Independent Review Board
      (or
      other) approval so that collection of subject data, needed for subsequent
      analysis, can proceed. Currently there are only two data sets available, and
      these will not be enough to test algorithm robustness. 8-20 data sets would
      be
      more appropriate for robustness testing.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    Phase
      II Tasks: Low-level Design, Coding, Testing and Validation

     

    Phase
      II
      Tasks, as defined in this proposal, are those tasks whose levels of effort
      cannot
      be
      accurately estimated until after all requirements and high-level design issues
      have been addressed. This is due to the unknowns associated with the
      experimental nature of this project. ASG believes that new or changed
      requirements - and their impact on the overall design - will be minimal and
      therefore is comfortable estimating the remaining level of effort to ±12%. Prior
      to the performance of any of the Phase II Tasks outlined herein, the parties
      shall execute a written agreement setting forth the terms and conditions,
      including the pricing, relating to the Phase II Tasks. Such written agreement
      may either be in the form of an amendment to this Agreement or an additional
      agreement between the parties. 

     

    These
      tasks are specified in the table below.

     

    
      	
              Phase
                II: ASG Engineering Estimates by Task

            	
              Effort
                (Hours)

            
	 	 
	
               Low-Level
                Design Effort

              ·  Low-level
                software definition

              ·  Coding
                and module testing

              ·  Traceability
                analysis

              ·  Design
                reviews

              ·  Code
                reviews

            	
              1792
                ±12%

            
	
               Design
                Verification

              ·  Integrate
                to target platform

              ·  Low-level
                regression testing

              ·  Function
                validation - test execution

              ·  Function
                validation - Evaluation

              ·  Function
                validation - Test Report

            	
              212
                ±12%

            
	
               Beta
                Design

              ·  Redesign
                for optimization

              ·  Re-validation

            	
              520
                ±12%

            
	
               Total
                Phase II Tasks (hours)

            	
              2524
                ±12%

            
	
               Phase
                II Duration (Weeks)

            	
              35

            
	
               Phase
                II Engineering Cost

            	
              Approx.
                $201,920 ±12%

            
	
               Phase
                II PM/QA Cost

            	
              $59,500

            
	
               Phase
                II Travel Cost (Estimated)

            	
              $5,250
                to $7,500

            
	
               Phase
                II Total

            	
              $230,100
                to $293,560

            
	 	 
	
               Project
                Duration in Months

            	
              10
                to 12

            

    

     

    One
      concern with the Phase II tasks is that the hardware developer will probably
      not
      be able to deliver a breadboard prototype unit until well into the Alpha
      Development phase. ASG and the hardware developer will work to determine if
      a
      generic or partially-functional development board can be made available for
      ASG’s use, so that coding tasks are not impacted by board
      availability.

     

    Notes
      and Assumptions

     

    Reasonable
      non-labor expenses (travel expenses, meals, hotel) will be billed to Scivanta
      at
      cost.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    Several
      engineering assumptions were clarified during the project kickoff meeting.
      ASG’s
      assumption that the hardware developer would assume responsibility for the
      low-level software (electronics interface and pump control) is correct; ASG
      does
      not reflect any hours in our schedule to perform those tasks. All other ASG
      assumptions have not changed, and include:

     

    	· 
              	
            ASG
              assumes that the device will be regarded for FDA purposes as a minor
              level
              of concern. This significantly shortens the coding/testing phase as
              code
              modules are not as stringently controlled, documented and tested as
              they
              would be under more moderate levels of concern. Functional testing
              -
              testing to the system requirements - is still required for all
              software.

          

    	· 
              	
            ASG
              assumes that IRB (or equivalent) approvals will be in place in a timely
              manner so that the Catheter Position algorithm can be tested and developed
              with more than the two data sets currently available for
              analysis.

          

    	·  
             	
            ASG
              assumes that for program continuity, if outside FDA consultants are
              hired
              that they will be hired at the program management level (we assume
              that
              Ethox is likely to take this role and provide FDA consultants, if
              necessary, to the project). Ethox may defer this role to the instrument
              manufacturer or to ASG. The level of effort for an FDA consultant can
              probably be measured as a fraction of a week (20-40%) for the duration
              of
              the project.

          

    	·  
             	
            Additional
              engineering hours for support during Pilot manufacturing runs are not
              included, nor is any manufacturing support software development effort
              included in this estimate.

          

     

    Please
      note that any time on site at customer’s facility during which the system is not
      available for ASG personnel to perform the quoted work will be billed as “out of
      scope” and shall be billed to Scivanta at an hourly rate of $80 per hour and
      $85/hr for Project management or Quality assurance tasks. However, before
      proceeding to provide such out of scope effort the ASG engineer will obtain
      prior written approval from Scivanta.

    

    Any
      on
      site work will be limited to a period of no more than 8 hours per day, 40 hours
      per week, Monday through Friday. Working hours are during the customer’s normal
      day shift operations.

     

    Use
      of Proprietary Material

     

    All
      equipment, procedures and documentation made available to ASG
      and its
      representatives in connection with this project shall be considered proprietary
      to
      Scivanta, and the Confidential Information of Scivanta. Such Confidential
      Information shall only be disclosed to employees of ASG, the hardware developer
      or Ethox as needed to perform the duties in connection with this scope of work.
      ASG agrees that it shall (i) hold the Confidential Information in strictest
      confidence to avoid disclosure and (ii) not use the Confidential Information
      for
      any purpose except as expressly contemplated under this Agreement.

     

    Safety
      Issues

     

    Personal
      safety issues with regard to any on-site work will be determined and addressed
      prior to the start of any on-site work. ASG
      employees will be made aware of all safety requirements, documentation and/or
      personal protective equipment (PPE) that may be necessary to insure their safety
      while on site. ASG shall be solely responsible for insuring employee safety
      on-site and complying with any and all federal, state and local workplace laws
      and regulations. 

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    Post
      -Delivery Support

     

    ASG’s
      shall provide continuing software support and to be available to perform
      additional work review for a period of 7 years following delivery of the
      software.

     

    Section
      II: Engineering/Programming Estimate 

     

    The
      following table indicates the requirements for the Hickey Cardiac Monitoring
      System. Upon award of contract, specific dates will be assigned to each item,
      with all dates reviewed by ASG
      and
      Ethox program management, and approved by Scivanta.

     

    Phase
      I:

     

    
      	
              Task

            	 	
               Fixed-Price
                Tasks

            	 	
              Cost

            	 
	
              1

            	 	 	
              Review
                and Document Existing Software

            	 	
              $

            	
              17,920

            	 
	
              2

            	 	 	
              Re-Analyze
                and Develop Catheter Positioning Algorithm

            	 	
              $

            	
              24,640

            	 
	
              3

            	 	 	
              Develop
                System Specification(s)

            	
               

            	
              $

            	
              18,880

            	 
	
              4

            	 	 	
              Develop
                and Document High-Level Software Design

            	 	
              $

            	
              19,520

            	 
	
            	 	 	
              PM/QA
                associated with above tasks 

            	 	
              $

            	
              22,100

            	 
	
            	 	 	
              Travel
                associated with above tasks 

            	 	
              $

            	
              2,500

            	 
	
            	 	 	
              Totals 

            	 	
              $

            	
              105,240

            	 

    

    

    Phase
      II:

     

    
      	Task	 	 	
              Estimated
                Cost Tasks 

            	 	 	
              Estimated
                Cost

            	 
	 	 	 	 	 	 	
              Low

            	 	 	
              High

            	 
	
              5

            	 	 	
              Develop
                and Document Low-Level Design, Coding and Testing

            	 	
              $

            	
              112,230

            	 	
              $

            	
              162,560

            	 
	
              6

            	 	 	
              Design
                Verification (Validation Testing and Documentation)

            	
               

            	
              $

            	
              14,720

            	 	
              $

            	
              19,200

            	 
	
              7

            	 	 	
              Beta
                Redesign

            	 	
              $

            	
              19,200

            	 	
              $

            	
              19,200

            	 
	
              8

            	 	 	
              Beta
                Revalidation

            	 	
              $

            	
              19,200

            	 	
              $

            	
              25,600

            	 
	
              9

            	 	 	
              PM/QA
                associated with above tasks

            	
               

            	
              $

            	
              59,500

            	 	
              $

            	
              59,500

            	 
	
              10

            	 	 	
              Travel
                associated with above tasks

            	 	
              $

            	
              5,250

            	 	
              $

            	
              7,500

            	 
	
            	 	 	
              Totals
                (PM/QA/Travel) 

            	 	
              $

            	
              230,010

            	 	
              $

            	
              293,560

            	 
	 	 	 	 	 	 	 	 	 	 	 
	
            	 	 	
              Grand
                Total 

            	 	
              $

            	
              335,250

            	 	
              $

            	
              398,800

            	 
	 	 	 	 	 	 	 	 	 	 	 

    

     

    Section
      III: Deliverables

     

    All
      source code will become the property of Scivanta, and all code will be
      adequately developed in accordance with FDA standards for a minor level of
      concern device.

     

    Deliverables
      will include

     

    	·  
              	
            Reports
              associated with all invoices indicating task completion
              status

          

    	·  
             	
            Source
              code that will meet the requirements as specified by the design team
              (Scivanta, Ethox, the hardware developer and ASG) during the Phase
              I tasks
              (see section I, above)

          

    	·  
             	
            Design
              History File associated with software
              development

          

    	· 
              	
            Test
              procedures

          

    	·  
             	
            Test
              reports demonstrating that the software was tested against those
              procedures

          

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    Section
      IV: Terms and Conditions

     

    

    
      	
              Billing:  
                

            	
              Phase
                I - Fixed Cost Contract;

              Phase
                II - Time & Materials Contract;

              ·  
                Progress
                Payments electronically invoiced biweekly for the duration of

                   contract.

            
	
              Payment:  
                

            	
              Net
                30 days upon receipt of invoice. A 1.5% late fee will be assessed
                beyond
                net 30 days and every 30 days thereafter.

            
	
              Terms:  
                

            	
              See
                Attachment A, “2007 Standard Terms and Conditions”; This proposal is valid
                for 30 days.

            
	
              Billing
                Rates:   

            	
              Engineering
                at   $80
                per hour

              PM/QA
                at          $85
                per hour

            
	
              Estimated
                Engineering Hours:   

            	
              3,040
                to 4,032

            	 
	
              Engineering
                Estimate, Phase I:   

            	
              $80,640

            	 
	
              PM/QA
                Estimate, Phase I:   

            	
              $22,100

            	 
	
              Travel
                Estimate, Phase I:   

            	
              $2,500

            	 
	
              Phase
                I Subtotal:   

            	
              $105,240

            	 
	
              Engineering
                Estimate, Phase II   

            	
              $165,260
                to $226,560

            	 
	
              PM/QA
                Estimate, Phase II   

            	
              $59,500

            	 
	
              Travel
                Estimate, Phase II   

            	
              $5,250
                to $7,500

            	 
	
              Phase
                II Subtotal:   

            	
              $230,010
                to $293,560

            	 
	
              Estimated
                Total, Both Phases:   

            	
              $335,250
                to $398,800

            	 

    

     

    Should
      you have any questions, or require additional information, please feel free
      to
      contact me at your convenience at (716) 626-5100.

     

    Respectfully,

     

    /s/
      Ben Castro

    Ben
      Casto        2
      July
      2007

    Sales
      Manager

     

    Applied
      Sciences Group, Inc.

    305
      Cayuga Rd., Suite 100

    Buffalo,
      NY 14225

    Phone 
      (716)
      626-5100

    Fax      
      (716)
      626-0629

    

    Accepted:

    

    Scivanta
      Medical Corporation

    

    By:
      /s/
      Thomas S.
      Gifford                                                     

          
      Executive Vice President and Chief Financial Officer

    

    Date: 
      July
      2, 2007

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    Attachment
      A: Applied Sciences Group, Inc. 

     

    2007
      Standard Terms & Conditions

     

     

    The
      following terms and conditions constitute a part of all Applied Sciences Group,
      Inc. (“ASG”) quotations or proposals and shall apply to any resulting purchase
      orders or contracts unless otherwise acknowledged in writing by ASG. Scivanta
      Medical Corporation (the “Purchaser”), by placement of an order, acknowledges
      their agreement to these Terms and Conditions.

     

    	1.     
              	
            Scope
              of Work.
              Any changes to the scope of the work post-award may be subject to
              additional charges and must be approved, in writing, by ASG. Any items
              not
              expressly included in the proposal are excluded. Any changes in drawings
              and/or specifications as to any material and/or work covered by
              Purchaser’s Order, resulting in a difference in price or time for
              performance resulting from such changes shall be equitably adjusted
              and
              the order and/or schedule shall be modified in writing signed by the
              parties accordingly.

          

     

    	2.     
              	
            Billing.
              Progress payments will be invoiced at specified intervals for the duration
              of the contract, as outlined in the proposal. Changes must be agreed
              to in
              writing by ASG. In the event Purchaser suspends or cancels a project
              after
              the start of work, Purchaser shall be responsible for all work performed
              and costs incurred by ASG prior to such suspension or
              cancellation.

          

     

    	3.      
             	
            Payment.
              Unless otherwise agreed in writing, payment for goods and services
              delivered by ASG shall be net 30 days after the invoice date for such
              goods and services. A 1.5% late fee will be assessed beyond net 30
              days
              and every 30 days thereafter. Should ASG obtain the services of a
              collection agency or attorney to resolve payments over 90 days late,
              any
              collection agency or attorney fees will be the responsibility of the
              Purchaser.

          

     

    	4.      
             	
            Schedule.
              Quoted schedules are subject to change at the time of order placement
              based on current ASG backlog. ASG shall notify Purchaser at the time
              of
              order if any such delay due to backlog will occur. Quoted schedules
              exclude weekends or holidays unless otherwise stated and exclude customer
              review time unless otherwise stated. Every effort will be made to hold
              delivery dates. ASG shall not be liable for delays or defaults in
              deliveries due to causes beyond its control and without its fault or
              negligence. If at any time ASG has reason to believe that delivery
              will
              not be made as scheduled, written notice setting forth, the causes
              of the
              anticipated delay will be given immediately to the Purchaser and project
              team. Any delay due to fault of subcontractors will be excusable, only
              if
              beyond the control and without the fault or negligence of both ASG
              and its
              subcontractor and only if ASG established that it could not obtain
              supplies or services from any other source in time to meet the delivery
              schedule.

          

     

    	5.     
              	
            Acceptance.
              This quotation does not constitute an acceptance by ASG of any terms
              and
              conditions not stated herein. References in this quotation or resulting
              contract or purchase order, to any offer, counter offer, or other document
              shall in no way constitute a modification of any of the terms and
              conditions of this quotation. ANY ATTEMPTED ACKNOWLEDGEMENT OF THIS
              QUOTATION CONTAINING TERMS AND CONDITIONS INCONSISTENT WITH, OR IN
              ADDITION TO, THE TERMS AND CONDITIONS PRESENTED HEREIN IS NOT BINDING
              UPON
              ASG UNLESS EXPRESSLY ACCEPTED BY ASG IN
              WRITING.

          

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    	6.     
              	
            Warranty
              for Engineering and Programming Design Services, Limitation of
              Liability.
              ASG warrants that the services it provides shall be performed in a
              competent and professional manner and in conformance with agreed upon
              standards. Purchaser’s sole remedy shall be the reperformance of services
              to provide corrective action or refund amounts paid for the services,
              at
              Purchaser’s option,. IN NO EVENT WILL ASG BE RESPONSIBLE FOR INCIDENTAL OR
              CONSEQUENTIAL DAMAGES EVEN IF THE COMPANY WAS AWARE OF THE POTENTIAL
              FOR
              SUCH DAMAGES. ALL OTHER WARRANTIES ARE EXPRESSLY
              DISCLAIMED.

          

     

    	7.     
              	
            Warranty
              for Commercial Goods, Limitation of Liability.
              ASG warrants that all goods sold by the Company shall be of good quality
              and free from defects in workmanship and materials and shall perform
              in
              accordance with the product specifications as of the date of delivery
              to
              the F.O.B. point. IN NO EVENT WILL ASG BE RESPONSIBLE FOR INCIDENTAL
              OR
              CONSEQUENTIAL DAMAGES EVEN IF THE COMPANY WAS AWARE OF THE POTENTIAL
              FOR
              SUCH DAMAGES. ALL OTHER WARRANTIES ARE EXPRESSLY DISCLAIMED. Warranty
              claims must be made in writing within 90 days from the date of delivery
              to
              the F.O.B. point. ASG shall repair, replace or refund amounts paid,
              at its
              discretion, for any claims covered by this warranty. This warranty
              is
              limited to the sale of goods and materials only and does not apply
              to
              services. This warranty does not apply to product deficiencies resulting
              from designs or specifications which have been provided by the
              Purchaser.

          

    

    	8.     
              	
            Assignment
              -
              No contract or any interest therein, resulting from this quotation,
              shall
              be assigned or transferred by either party except as expressly authorized
              in writing by the other party, and any attempted assignment without
              such
              consent shall be void. Notwithstanding the foregoing, Scivanta
              may assign this Agreement to an affiliate or in connection with any
              merger, reorganization or sale of substantially all of Scivanta assets
              or
              other change of control transaction without any consent from
              ASG.

          

    

    	9.      
             	
            Federal,
              State, and Local Taxes
              -
              Except as expressly provided in this quotation, prices exclude Federal,
              State and Local taxes and duties. Such taxes or duties, if collected
              by
              ASG, will appear as a separate charge on the
              invoice.

          

    

    	10.    
             	
            Disputes -
              In the event that any dispute, arising under or relating to a contract
              resulting from this quotation, cannot be resolved by settlement between
              the parties or by an Alternative Dispute Resolution technique agreed
              to by
              all parties, either party may litigate any such dispute. Purchaser
              agrees
              to the exclusive jurisdiction and venue of the courts presiding in
              Monmouth County, New Jersey for all disputes arising
              hereunder.

          

    

    	11.   
              	
            Applicable
              Law
              -
              It is agreed that contracts associated with this quotation shall be
              construed, interpreted and governed by the internal Laws of the State
              of
              New York, without regard to principals of conflicts of
              law.

          

    

    	12.    
             	
            Permits
              and Compliance to Applicable Rules/Regulations
              -
              Except as otherwise agreed to by ASG, the Purchaser shall procure all
              necessary permits or licenses required due to the special nature of
              services requested by the Purchaser, and abide by all applicable laws,
              regulations and ordinances of the United States and the State, territory
              and political subdivision in which the work under contract is
              performed.

          

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    
 

    	13.    
             	
            Intellectual
              Property
              -
              It is the responsibility of the Purchaser to ensure that products or
              services provided by ASG at the Purchaser’s request or direction do not
              violate any patents existing or pending. Moreover, the Purchaser assumes
              full liability for any such patent infringements, and agrees to indemnify
              and defend ASG against any such liability. Purchaser’s liability to ASG
              relating to a patent infringement claim shall be limited to the amounts
              paid to ASG hereunder.

          

    

    To
      the
      extent that ASG utilizes its own pre-existing intellectual property, including
      but not limited to methods, processes, or inventions (the “ASG Intellectual
      Property”), ASG represents and warrants that the ASG Intellectual Property
      utilized in performing the services provided to Scivanta hereunder and the
      results of such services will not infringe upon any patent, copyright,
      trademark, trade secret or other intellectual property right of any third party.
      ASG shall indemnify defend, and hold harmless Scivanta, including its officers,
      directors, and employees, agents and contractors, from and against any and
      all
      judgments, liabilities, claims, demands, expenses, losses or costs (including
      attorneys’ fees) arising from or relating to any third party intellectual
      property infringement claim in connection with the ASG Intellectual Property
      or
      ASG’s provision of services hereunder. 

    

    	14.    
             	
            Invention
              and Assignment- ASG
              agrees that all right, title and interest in and to all information,
              data,
              inventions, discoveries, developments, creative works, ideas, products,
              systems, computer programs, object code, source code, computer algorithms
              and related documentation, including improvements or modifications
              thereto, and works of authorship, whether or not patentable, copyrightable
              or subject to other forms of protection, made, created, developed,
              written
              or conceived by ASG or ASG employees during the term of this Agreement
              in
              the performance of duties relating to the subject matter of this Agreement
              (collectively the “Intellectual Property”), to the greatest extent
              permitted by law, constitute works for hire and are the sole and exclusive
              property of Scivanta from the moment of its
              creation.

          

    

    To
      the
      extent that any Intellectual Property created by ASG in the performance of
      its
      duties hereunder does not constitute a work for hire, or does not constitute
      the
      sole and exclusive property of Scivanta, as provided above, ASG hereby assigns
      and agrees to assign to Scivanta all of ASG’s right, title, and interest in and
      to all such Intellectual Property.

    

    ASG
      agrees that it shall, at Scivanta’s expense, execute a specific assignment of
      title to the Intellectual Property to Scivanta and do anything else reasonably
      necessary or desirable to enable Scivanta to secure a patent, copyright or
      other
      form of protection for or otherwise exploit, preserve, defend or enforce any
      Intellectual Property right anywhere in the world. 

    

    ASG’s
      obligations under this Section 14 shall survive the termination of ASG’s
      engagement by Scivanta for any reason.

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    
 

    	15.    
             	
            Insolvency
              -
              If Purchaser ceases to conduct its operations in the normal course
              of
              business, including inability to meet its obligations as they mature,
              or
              if any proceeding under the bankruptcy or insolvency laws is brought
              by or
              against Purchaser, or a receiver for Purchaser is appointed or applied
              for, or an assignment of creditors is made by the Purchaser, ASG, to
              the
              extent permitted by law, may terminate the contract without
              liability.

          

    

    	16.    
             	
            Cancellation -
              If the Purchaser chooses to cancel any contract or order associated
              with
              this quotation, written notice must be given to and acknowledged by
              ASG
              during normal work hours. ASG will stop work in progress, whereupon
              it
              will invoice the Purchaser for all applicable services rendered, including
              labor, materials, outside services, and fees, up to the time of
              cancellation. Labor charges will be calculated based on ASG’s standard
              hourly rates. Payment shall be due within 15 working days of such
              cancellation.

          

    

    	17.    
             	
            Order
              of Precedence
              -
              In the event of an inconsistency between the provisions of these terms
              and
              conditions and the provisions of any other documents exchanged, or
              agreements made between the parties, these terms and conditions shall
              supersede any inconsistent provision in such other documents or
              agreements, unless expressly amended by a written agreement making
              specific reference to the provisions being
              amended.

          

    

    	18.   
              	
            Attorneys’
              Fees and Costs
              -
              In connection with any litigation arising out of the Agreement, the
              prevailing party shall be entitled to recover all of its costs and
              expenses incurred including actual attorneys’ fees for services rendered
              in connection with such litigation, including its proceedings and
              post-judgment proceedings. As used herein, the term “attorneys’ fees”
              shall be deemed to include charges for paralegal law clerks and other
              staff members operating under the supervision of an attorney and for
              all
              sales and/or use taxes imposed thereon by an appropriate governmental
              authority.

          

    

    	19.   
              	
            LIMITATION
              OF WARRANTIES
              -
              THE WARRANTIES STATED IN PARAGRAPHS 6 AND 7 OF THESE TERMS AND CONDITIONS
              ARE GIVEN IN PLACE OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, OF
              MERCHANTABILITY, FITNESS FOR USE, OR OTHERWISE. NO PROMISE OR AFFIRMATION
              OF FACT MADE BY ANY AGENT OR REPRESENTATIVE OF ASG SHALL CONSTITUTE
              A
              WARRANTY BY ASG OR GIVE RISE TO ANY LIABILITY OR OBLIGATION. ASG SHALL
              NOT
              BE LIABLE IN ANY EVENT FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES AS THOSE
              TERMS ARE DEFINED IN ARTICLE 2 OF THE NEW YORK UNIFORM COMMERCIAL
              CODE.
              The warranties granted by ASG are terminated and ASG shall not be liable
              to Purchaser or any other person for any damage, injury or loss arising
              out of the use of any goods or services, whether by reason of any defect
              in the goods or services furnished hereunder or otherwise, if, prior
              to
              such damage, injury or loss, the goods or services are (a) damaged
              or
              misused after tender of delivery, (b) repaired, altered or modified
              without ASG’s written consent, or (c) not used, maintained, operated or
              applied in strict compliance with instructions supplied by
              ASG.

          

    

    	20.    
             	
            Force
              Majeure
              -
              ASG shall not be liable for nonperformance or delay in performance
              due
              wholly or partly to commercial impracticability or any cause not wholly
              or
              exclusively in its control or which it could not by reasonable diligence
              have avoided. Upon the occurrence of any such contingency, ASG shall
              have
              the right to suspend or reduce deliveries during the period of such
              contingency, and the total quantity deliverable under this contract
              shall,
              at ASG’s election, be reduced by the quantities so omitted. The following
              shall not be considered wholly or exclusively within ASG’s control: fire;
              flood; earthquake; storm; acts of God; labor controversies; court decrees;
              inability to use the full capacity of plants or facilities as a result
              of
              government action, and inability to obtain fuel, power, raw materials,
              labor, containers or transportation facilities, without litigation
              or the
              payment of penalties.

          

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

    
 

    	21.    
             	
            NON-Recruitment
              Clause:
              When ASG and Purchaser enter this contract, in which various employees
              of
              the ASG will be performing services at the Purchaser’s premises and/or
              other such locations, Purchaser recognizes and agrees that such employees
              of ASG are of great value to ASG and that the loss of their services
              to
              ASG would cause substantial damage to ASG for which there would be
              no
              adequate remedy at law. Purchaser therefore agrees that during the
              time
              ASG is performing services for the Purchaser, and for a period of one
              year
              thereafter, the Purchaser will not:

          

    	·  
             	
            solicit
              for employment (directly or through a third party), as the Purchaser’s
              employee or as an independent consultant, any ASG’s employee who provided
              services to the Purchaser;

          

    	· 
              	
            Employ
              any ASG’s employee as the Purchaser’s employee or an independent
              consultant.

          

    

    Purchaser
      further agrees that in the event this agreement is violated, ASG shall be
      entitled to an injunction restraining any further violation - in addition to
      any
      other right or remedy to which the ASG might be entitled in law or in equity.
      However, in the event that both the Purchaser and ASG agree that it is in ASG’s
      employee’s best interest to entertain a job offer from the Purchaser, then ASG
      will be compensated by the Purchaser as follows:

    	· 
              	
            When
              a job offer is accepted by the ASG’s employee, the Purchaser shall pay a
              lump sum equal to 20% of the employee’s first year’s salary, plus any
              training and recruitment costs incurred by ASG in the 12 months prior
              to
              the offer being accepted.

          

    

    	22.    
             	
            Entire
              Agreement
              -
              This Contract constitutes the entire agreement between the parties
              and may
              be modified only in writing and the agreed to by both parties. Neither
              ASG
              nor the Purchaser will be bound by any oral agreement or representation
              irrespective of whom or when made.

          

     

    
 

    
      
         

      

      
        12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]